Rectamid is a polyacrylamide hydrogel being developed as a minimally invasive, effective and safe
treatment for faecal incontinence.
Based upon Contura’s proprietary hydrogel technology, Rectamid seeks to address the need for a
treatment that is more effective than conservative management, but much less invasive than
complex and expensive surgical procedures such as sphincter reconstruction or
sacral nerve stimulation.
